- Home
- AMTD vs BOLD Comparison
AMTD vs BOLD Comparison
Compare AMTD & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTD
- BOLD
- Stock Information
- Founded
- AMTD 2003
- BOLD 2018
- Country
- AMTD France
- BOLD United States
- Employees
- AMTD N/A
- BOLD N/A
- Industry
- AMTD
- BOLD
- Sector
- AMTD
- BOLD
- Exchange
- AMTD Nasdaq
- BOLD Nasdaq
- Market Cap
- AMTD 78.6M
- BOLD 81.0M
- IPO Year
- AMTD 2019
- BOLD 2024
- Fundamental
- Price
- AMTD $1.13
- BOLD $3.01
- Analyst Decision
- AMTD
- BOLD Strong Buy
- Analyst Count
- AMTD 0
- BOLD 3
- Target Price
- AMTD N/A
- BOLD $23.00
- AVG Volume (30 Days)
- AMTD 23.2K
- BOLD 64.0K
- Earning Date
- AMTD 12-30-2024
- BOLD 11-07-2024
- Dividend Yield
- AMTD N/A
- BOLD N/A
- EPS Growth
- AMTD N/A
- BOLD N/A
- EPS
- AMTD 2.37
- BOLD N/A
- Revenue
- AMTD $122,715,000.00
- BOLD N/A
- Revenue This Year
- AMTD N/A
- BOLD N/A
- Revenue Next Year
- AMTD N/A
- BOLD N/A
- P/E Ratio
- AMTD $0.48
- BOLD N/A
- Revenue Growth
- AMTD N/A
- BOLD N/A
- 52 Week Low
- AMTD $1.13
- BOLD $2.82
- 52 Week High
- AMTD $2.04
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- AMTD 32.12
- BOLD N/A
- Support Level
- AMTD $1.30
- BOLD N/A
- Resistance Level
- AMTD $1.33
- BOLD N/A
- Average True Range (ATR)
- AMTD 0.05
- BOLD 0.00
- MACD
- AMTD -0.01
- BOLD 0.00
- Stochastic Oscillator
- AMTD 0.00
- BOLD 0.00
About AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.